Table 2 Tissue to plasma exposure ratio of paclitaxel for tumor, liver, and spleen following intravenous administration
Tissue to plasma ratio | Formulation | |
---|---|---|
Cremophor EL:ethanol | Nanosuspension | |
Tumor AUC0-8/plasma AUC0-8 | 0.7 | 8.3 |
Liver AUC0-8/plasma AUC0-8 | 3.6 | 810.0 |
Spleen AUC0-8/plasma AUC0-8 | 1.1 | 16.8 |